During the corresponding time, Societal Cdmo Inc recorded a revenue increase by 14.17 % year on year, sequentially revenue grew by 17.5 %. While revenue at the Societal Cdmo Inc 's corporate clients
Societal Cdmo Inc's Comment on Sales, Marketing and Customers
The company provides clinical trial support services, including over-encapsulation, comparator sourcing, packaging, labeling, storage, and distribution. It operates bi-coastally to serve clients in the U.S. and internationally. Its customers include biotechnology and pharmaceutical companies outsourcing formulation and manufacturing operations. The company supports three market segments: commercial oral solid dose products, including commercial tech transfer; legacy profit-sharing products such as Verapamil; and early-stage development clients. It develops targeted sales strategies for each segment and has rebranded as Societal™ CDMO to enhance its presence in the biopharma market. The company aims to optimize and expand its capabilities to serve a growing customer base and attract new clients.
Societal CDMO and Benuvia Sign Co-Marketing Agreement to Boost Drug Development Services in Thriving Psychedelic and Cannabinoid MarketsTwo prominent players in the contract development and manufacturing organization (CDMO) and active pharmaceutical ingredient (API) manufacturing services, Societal CDMO and Benuvia, have recently joined forces through a co-marketing agreement aimed at propelling drug development services across various therapeutic areas. The partnership, which extends its reach to the rapidly growing psychedelic and cannabinoid drug development markets, promises to provide significant benefits to drug developers in need of comprehensive and complementary services.Societal CDMO has built a so...
Societal Cdmo Inc’s Comment on Sales, Marketing and Customers
The company provides clinical trial support services, including over-encapsulation, comparator sourcing, packaging, labeling, storage, and distribution. It operates bi-coastally to serve clients in the U.S. and internationally. Its customers include biotechnology and pharmaceutical companies outsourcing formulation and manufacturing operations. The company supports three market segments: commercial oral solid dose products, including commercial tech transfer; legacy profit-sharing products such as Verapamil; and early-stage development clients. It develops targeted sales strategies for each segment and has rebranded as Societal™ CDMO to enhance its presence in the biopharma market. The company aims to optimize and expand its capabilities to serve a growing customer base and attract new clients.
Sources:
Societal Cdmo Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Societal Cdmo Inc’s corporate clients.
For your research, we’ve provided 9 tables on Societal Cdmo Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
